Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review.
Dos Santos CCM, Uggioni MLR, Colonetti T, Colonetti L, Grande AJ, Da Rosa MI.
J Sex Med. 2021 Jan;18(1):156-166. doi: 10.1016/j.jsxm.2020.10.016. Epub 2020 Dec 5.
Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.
Potter N, Panay N.
Climacteric. 2021 Feb;24(1):19-24. doi: 10.1080/13697137.2020.1820478. Epub 2020 Sep 29.
Ospemifene and vulvovaginal atrophy: an update of the clinical profile for post-menopausal women.
Di Carlo C, Cagnacci A, Murina F, Maffei S, Becorpi A, Lello S.
Expert Opin Pharmacother. 2024 Aug;25(11):1541-1554. doi: 10.1080/14656566.2024.2391009. Epub 2024 Aug 13.
Fox-Fordyce disease.
Yost J, Robinson M, Meehan SA.
Dermatol Online J. 2012 Dec 15;18(12):28.
Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion.
Liu JH, Bernick B, Mirkin S.
Expert Opin Drug Deliv. 2020 Nov;17(11):1573-1581. doi: 10.1080/17425247.2020.1810662. Epub 2020 Sep 2.
Plasma cell vulvitis: A systematic review.
Sattler S, Elsensohn AN, Mauskar MM, Kraus CN.
Int J Womens Dermatol. 2021 May 4;7(5Part B):756-762. doi: 10.1016/j.ijwd.2021.04.005. eCollection 2021 Dec.
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part I: Evaluation of efficacy.
Di Donato V, Schiavi MC, Iacobelli V, D'oria O, Kontopantelis E, Simoncini T, Muzii L, Benedetti Panici P.
Maturitas. 2019 Mar;121:86-92. doi: 10.1016/j.maturitas.2018.11.016. Epub 2018 Nov 24.
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part II: Evaluation of tolerability and safety.
Di Donato V, Schiavi MC, Iacobelli V, D'oria O, Kontopantelis E, Simoncini T, Muzii L, Benedetti Panici P.
Maturitas. 2019 Mar;121:93-100. doi: 10.1016/j.maturitas.2018.11.017. Epub 2018 Nov 28.
Non-hormonal treatments for managing vulvovaginal atrophy/genitourinary syndrome of menopause.
Cox P, Panay N.
Climacteric. 2023 Aug;26(4):367-372. doi: 10.1080/13697137.2023.2210283. Epub 2023 May 18.
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.
Constantine GD, Simon JA, Pickar JH, Archer DF, Kushner H, Bernick B, Gasper G, Graham S, Mirkin S; REJOICE Study Group.
Menopause. 2017 Apr;24(4):409-416. doi: 10.1097/GME.0000000000000786.
